
    
      After being informed of the study and the potential risks, all patients matching the
      eligibility criteria and who have given their written consent will undergo a gel injection at
      day 0 after a period of screening of up to 14 days.

      Then, they will be followed-up for a variable period according to the cohort :

        -  first cohort of 5 patients with only one disc to be treated will be followed during 48
           weeks,

        -  second cohort of 5 patients with 2 discs to be treated will be followed during 36 weeks,

        -  third cohort of 10 patients with 1 or 2 discs to be treated will be followed during 24
           weeks.
    
  